P

Pfizer

Makes cancer drugs, vaccines and other medicines

Engineering and Maintenance Manager

Full-TimePosted on 10/21/2026Deadline 10/28/26
$116k - $193.4k/yr+ 15% bonus target + Share-based long-term incentive program
Mid
Bachelor's, Master's, PhD, Associate's
Sanford, NC, USA
In PersonOn-premise; occasional travel to other sites, conferences, supplier facilities, and vendor locations may be required.
General Maintenance & RepairEquipment Maintenance
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree with at least 4 years of experience, or a master's degree with at least 2 years of experience, or a PhD with 0+ years of experience, or an associate's degree with 8 years of experience, or a high school diploma (or equivalent) and 10 years of relevant experience in Engineering, Maintenance, Manufacturing, Technical Operations, Reliability, Quality, or related technical disciplines.
  • At least 3 years of direct supervisory, leadership, or people management experience.
  • Technical, leadership, administrative, computer, AI, communication, and presentation skills; demonstrated experience managing department-level engineering or maintenance activities, supporting manufacturing operations, guiding technical work, managing priorities, and coaching direct reports.
  • Technical and managerial competency, broad knowledge of engineering and maintenance practices, and ability to manage people, resources, priorities, and moderately complex work within a department.
  • Strong understanding of Process Safety Management elements.
  • Proficiency in Enterprise Asset Management solutions or other computerized maintenance management system applications.
  • Thorough knowledge of current Good Manufacturing Practices, FDA regulations, and current pharmaceutical industry standards.
  • Strong people management experience.
  • Communication and leadership skills.
  • Work may require nights, weekends, holidays, or extended hours to support manufacturing operations, shutdowns, maintenance activities, project execution, investigations, or emergency response activities.
  • Occasional travel to other Pfizer sites, industry conferences, supplier facilities, Factory Acceptance Testing activities, and vendor locations may be required.
  • Must be authorized to be employed in the United States by any employer; the position requires permanent work authorization in the United States.
Responsibilities
  • Manage department-level engineering and maintenance work activities and moderately complex projects supporting manufacturing operations, utility systems, facilities, and infrastructure.
  • Provide direct leadership, supervision, coaching, and performance management to engineering and maintenance colleagues; establish department goals, priorities, expectations, and development plans aligned with short-term department objectives.
  • Manage department people, technical, and financial resources, including recruitment, onboarding, training, goal setting, performance evaluation, salary administration support, workload prioritization, and colleague development.
  • Provide technical and functional guidance for assigned manufacturing equipment, utility systems, facilities, and infrastructure to ensure safe, reliable operation and compliance with internal standards and applicable regulations.
  • Oversee department maintenance and reliability programs, including preventive, predictive, corrective, and reliability-centered maintenance approaches.
  • Lead or support moderately complex capital and non-capital projects, including scope development, budget and schedule tracking, procurement support, contractor coordination, commissioning, qualification, verification, and project closure.
  • Support investigations, troubleshooting, root cause analysis, engineering change management, technical documentation updates, and corrective and preventive actions relating to equipment, facilities, utilities, and infrastructure systems.
  • Ensure department engineering and maintenance activities comply with current Good Manufacturing Practice requirements, quality systems, safety standards, internal procedures, and applicable regulations; support audits and inspections through preparation, document review, technical input, and implementation of assigned commitments.
  • Identify and implement department process, maintenance, reliability, safety, compliance, and productivity improvements using established continuous improvement and operational excellence tools.
  • Coordinate engineering and maintenance support for planned shutdowns, outages, maintenance campaigns, equipment upgrades, and operational readiness activities within assigned areas.
  • Communicate with department colleagues, cross-functional stakeholders, contractors, and internal partners to support alignment, timely execution, knowledge sharing, and issue resolution.
  • Support manufacturing operations, investigations, and change controls; maintain safe, reliable, compliant, and efficient operation of assigned assets.
  • Work in varied environments inside and outside buildings, with potential exposure to hazardous materials and energy sources, using appropriate personal protective equipment.
  • Work directly with utilities and process equipment, including aseptic processing equipment, bioreactors, tangential flow equipment, centrifuges, chromatography columns, HEPA filters, high-purity water systems including WFI, sanitary distribution, clean steam, process gases, and process control systems.
Desired Qualifications
  • Relevant pharmaceutical experience.
  • Experience supporting regulatory inspections, engineering change management, commissioning, qualification, verification, asset management, maintenance programs, and contractor coordination.
  • Industry experience with preventive and predictive maintenance programs.
  • Experience in equipment-based Root Cause Failure Analysis investigations.
  • Experience providing technical engineering oversight to develop project execution plans and associated engineering studies for equipment component installation.
  • Experience using common AI tools, including generative technologies such as ChatGPT or Microsoft Copilot, to support problem solving and enhance productivity; curiosity about how these tools can improve outcomes and understanding of responsible AI practices, including risk management and ethical use.

About the company

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Newer drugs carry the business: launched and acquired products grew 18% operationally in Pfizer's August 2026 quarterly report.
  • The outlook improved: in August 2026, Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion.
  • Vaccine scientists get room to grow: Pfizer's $470 million Pearl River, New York research expansion is designed for 370 workers.

What critics are saying

  • Expect more site cuts: in November 2025, Pfizer moved to shrink Swiss staff from about 300 to roughly 70.
  • Generics will erase sales: Pfizer expects patent losses to cut $17 billion to $18 billion of yearly revenue through 2028.
  • Pfizer is chasing obesity leaders: Metsera's monthly shot showed 12.3% weight loss at 28 weeks in February 2026 data.

What makes Pfizer unique

  • Pfizer bought its way into cancer: its Seagen buyout added antibody-drug conjugates, which carry chemotherapy straight to tumors.
  • Pfizer is betting on monthly obesity shots: Metsera's berobenatide is dosed once a month, unlike weekly Wegovy and Zepbound.
  • Pfizer leans on one partnered heart drug: blood thinner Eliquis, sold with Bristol Myers Squibb, brings about 14% of revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

6 month growth

-4%

1 year growth

-3%

2 year growth

-3%
Yahoo Finance
Oct 22nd, 2026
Pfizer's 5.7% yield signals risk: dividends took 108% of free cash flow vs Merck's 66%

Merck's dividend looks safer than Pfizer's, despite Pfizer's higher yield, according to a 24/7 Wall St. comparison. Pfizer yields about 5.7% against Merck's 2.2%. In 2025, Pfizer's dividends used 108% of free cash flow, while Merck's used 66%. In the first half of 2026, Merck's free cash flow covered 174% of its payout; Pfizer's covered about 51%. Merck has raised its quarterly dividend 39% since 2020, to $0.85. Pfizer's rose 13% and has been flat at $0.43 since January 2025. Pfizer is cheaper, at about 10 times 2026 earnings against Merck's 17. Pfizer targets a return to growth from 2029, while Merck's newer drugs are already selling.

Yahoo Finance
Oct 21st, 2026
Pfizer announces layoffs at Rocky Mount and Sanford sites, but gives no numbers

Pfizer has announced layoffs at its Rocky Mount and Sanford facilities in North Carolina, as part of a push to improve efficiency. It told employees of the cuts on Tuesday but did not say how many jobs will go, when, or in which departments. Rocky Mount makes sterile injectables, while Sanford focuses on vaccines and advanced biologics, including gene therapies. "Headcount reductions are a part of this initiative," Pfizer said, adding that it will give affected staff support services. "If indeed this happens, it's going to affect those families," said David Farris, president and chief executive officer of the Rocky Mount Area Chamber of Commerce. The impact on local economies, he said, depends on the number laid off. As of Wednesday afternoon, no Worker Adjustment and Retraining Notification (WARN) notice had been filed with the state.

Yahoo Finance
Oct 19th, 2026
Five low-beta dividend stocks: Pfizer yields 5.83%, Coca-Cola raises payout since 1999

Five defensive dividend stocks offer income with less volatility than the broader market, according to a 24/7 Wall St. analysis. All five have a beta well below 1, meaning they have historically moved less than the market. Pfizer leads with a forward yield of 5.83% at $29.49 a share. AT&T yields 4.77% at $23.27, and its $1.11 dividend uses about 42% of 2026 free cash flow guidance of $18B+. Debt of $144B is its main risk. Dominion Energy yields 4.24%, while Coca-Cola and Colgate-Palmolive each yield 2.27%. Coca-Cola has raised its dividend every year since 1999, and Colgate's next ex-dividend date is October 20, 2026.

Yahoo Finance
Oct 15th, 2026
GSK beats Pfizer as dividend stock: 39% payout vs 89% of free cash flow

GSK looks the better dividend stock than Pfizer, according to a comparison of the two drugmakers, which both face major patent losses before 2030. Pfizer yields 6.3% and GSK 4.1%. Over the twelve months to June 2026, Pfizer paid out 89% of its free cash flow in dividends ($9.79 billion of $10.98 billion), against 39% at GSK (£2.67 billion of £6.90 billion). Pfizer's chief executive officer, Albert Bourla, said the dividend will be maintained even in "the most stretched scenarios." Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion. GSK raised its dividend 17.6% in fiscal 2025 after an earlier cut, and Q2 2026 sales rose 5%. Its main risk is debt: net debt rose to £22 billion after the Nuvalent acquisition.

Yahoo Finance
Oct 14th, 2026
Pfizer's 6% dividend pays investors to wait as oncology pipeline drives growth beyond COVID-19

Pfizer offers a dividend yield of just over 6% while it builds growth beyond its COVID-19 products. The drugmaker declared a quarterly dividend of $0.43 in June 2026, its 351st consecutive quarterly payment. In the second quarter, revenue from launched and acquired products rose 18% year over year. Pfizer raised the midpoint of its full-year guidance, helped by stronger non-COVID sales from drugs such as Eliquis, Padcev, and Vyndaqel. Oncology is the next focus. Pfizer is investing in antibody-drug conjugates and bispecific antibodies, and it entered a global collaboration with Innovent Biologics covering 12 early-stage cancer programs. Not every experimental drug will succeed, but a broader pipeline improves the odds. If new medicines work, the share price could rise on top of the dividend income.